ID   CTBP1_RAT               Reviewed;         430 AA.
AC   Q9Z2F5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 3.
DT   07-APR-2021, entry version 179.
DE   RecName: Full=C-terminal-binding protein 1;
DE            Short=CtBP1;
DE            EC=1.1.1.-;
DE   AltName: Full=50 kDa BFA-dependent ADP-ribosylation substrate;
DE   AltName: Full=BARS-50;
DE   AltName: Full=C-terminal-binding protein 3;
DE            Short=CtBP3;
GN   Name=Ctbp1; Synonyms=Bars, Ctbp3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=10364211; DOI=10.1074/jbc.274.25.17705;
RA   Spano S., Silletta M.G., Colanzi A., Alberti S., Fiucci G., Valente C.,
RA   Fusella A., Salmona M., Mironov A., Luini A., Corda D.;
RT   "Molecular cloning and functional characterization of brefeldin A-ADP-
RT   ribosylated substrate. A novel protein involved in the maintenance of the
RT   Golgi structure.";
RL   J. Biol. Chem. 274:17705-17710(1999).
RN   [2]
RP   ERRATUM OF PUBMED:10364211.
RA   Spano S., Silletta M.G., Colanzi A., Alberti S., Fiucci G., Valente C.,
RA   Fusella A., Salmona M., Mironov A., Luini A., Corda D.;
RL   J. Biol. Chem. 274:25188-25188(1999).
RN   [3]
RP   SEQUENCE REVISION TO 259.
RA   Spano S., Silletta M.G., Colanzi A., Alberti S., Fiucci G., Valente C.,
RA   Fusella A., Salmona M., Mironov A., Luini A., Corda D.;
RL   Submitted (MAY-2001) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 275-294, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [5]
RP   FUNCTION, ADP-RIBOSYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7624370; DOI=10.1073/pnas.92.15.7065;
RA   Di Girolamo M., Silletta M.G., De Matteis M.A., Braca A., Colanzi A.,
RA   Pawlak D., Rasenick M.M., Luini A., Corda D.;
RT   "Evidence that the 50-kDa substrate of brefeldin A-dependent ADP-
RT   ribosylation binds GTP and is modulated by the G-protein beta gamma subunit
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7065-7069(1995).
RN   [6]
RP   INTERACTION WITH CTBP1, AND SUBCELLULAR LOCATION.
RX   PubMed=25652077; DOI=10.15252/embj.201488796;
RA   Ivanova D., Dirks A., Montenegro-Venegas C., Schoene C., Altrock W.D.,
RA   Marini C., Frischknecht R., Schanze D., Zenker M., Gundelfinger E.D.,
RA   Fejtova A.;
RT   "Synaptic activity controls localization and function of CtBP1 via binding
RT   to Bassoon and Piccolo.";
RL   EMBO J. 34:1056-1077(2015).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-349 IN COMPLEX WITH NADH,
RP   FUNCTION, AND MUTAGENESIS OF ALA-41 AND VAL-55.
RX   PubMed=12805226; DOI=10.1093/emboj/cdg283;
RA   Nardini M., Spano S., Cericola C., Pesce A., Massaro A., Millo E.,
RA   Luini A., Corda D., Bolognesi M.;
RT   "CtBP/BARS: a dual-function protein involved in transcription co-repression
RT   and Golgi membrane fission.";
RL   EMBO J. 22:3122-3130(2003).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 1-350 IN COMPLEX WITH NAD AND
RP   ZNF217, AND INTERACTION WITH ZNF217.
RX   PubMed=16940172; DOI=10.1128/mcb.00680-06;
RA   Quinlan K.G.R., Nardini M., Verger A., Francescato P., Yaswen P., Corda D.,
RA   Bolognesi M., Crossley M.;
RT   "Specific recognition of ZNF217 and other zinc finger proteins at a surface
RT   groove of C-terminal binding proteins.";
RL   Mol. Cell. Biol. 26:8159-8172(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) OF 1-350 OF MUTANT GLU-172, NAD
RP   BINDING, SUBUNIT, AND MUTAGENESIS OF GLY-172.
RX   PubMed=19351597; DOI=10.1016/j.bbrc.2009.02.010;
RA   Nardini M., Valente C., Ricagno S., Luini A., Corda D., Bolognesi M.;
RT   "CtBP1/BARS Gly172-->Glu mutant structure: impairing NAD(H)-binding and
RT   dimerization.";
RL   Biochem. Biophys. Res. Commun. 381:70-74(2009).
CC   -!- FUNCTION: Corepressor targeting diverse transcription regulators such
CC       as GLIS2 or BCL6. Has dehydrogenase activity. Involved in controlling
CC       the equilibrium between tubular and stacked structures in the Golgi
CC       complex. Functions in brown adipose tissue (BAT) differentiation.
CC       {ECO:0000269|PubMed:10364211, ECO:0000269|PubMed:12805226,
CC       ECO:0000269|PubMed:7624370}.
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC       Note=Cofactor binding induces a conformational change.;
CC   -!- SUBUNIT: Homo- or heterodimer. Heterodimer with CTBP2. Interacts with
CC       ELK3 (via its PXDLS motif). Interacts with RBBP8 (via its PXDLS motif);
CC       the interaction is disrupted by binding to adenovirus E1A. Interacts
CC       with PNN, MECOM and ZFHX1B. Interacts with ZNF366 (via PXDLS motif) (By
CC       similarity). Interaction with SATB1 (non-acetylated form); the
CC       interaction stabilizes its attachment to DNA and promotes transcription
CC       repression. Interacts with PRDM16; the interaction represses white
CC       adipose tissue (WAT)-specific genes expression. Interacts with GLIS2,
CC       HIPK2, FOXP1, FOXP2, HDAC4, HDAC5, HDAC9, NRIP1 and WIZ. Interacts with
CC       ZNF217. Interacts with BCL6; the interaction is required for BCL6
CC       transcriptional autoinhibition and inhibition of some BCL6 target
CC       genes. Interacts with IKZF4 (By similarity). Interacts with MCRIP1
CC       (unphosphorylated form, via the PXDLS motif); competitively inhibiting
CC       CTBP-ZEB1 interaction (By similarity). Interacts with Bassoon/BSN; this
CC       interaction targets and anchors CTBP1 to presynapses (PubMed:25652077).
CC       Interacts with SIMC1 (By similarity). {ECO:0000250|UniProtKB:O88712,
CC       ECO:0000250|UniProtKB:Q13363, ECO:0000269|PubMed:12805226,
CC       ECO:0000269|PubMed:16940172, ECO:0000269|PubMed:19351597,
CC       ECO:0000269|PubMed:25652077}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13363}. Nucleus
CC       {ECO:0000269|PubMed:25652077}. Cell junction, synapse, synaptosome
CC       {ECO:0000269|PubMed:25652077}.
CC   -!- PTM: The level of phosphorylation appears to be regulated during the
CC       cell cycle. Phosphorylation by HIPK2 on Ser-412 induces proteasomal
CC       degradation (By similarity). {ECO:0000250}.
CC   -!- PTM: ADP-ribosylated; when cells are exposed to brefeldin A.
CC   -!- PTM: Sumoylation on Lys-418 is promoted by the E3 SUMO-protein ligase
CC       CBX4. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the D-isomer specific 2-hydroxyacid
CC       dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF067795; AAC79427.2; -; mRNA.
DR   RefSeq; NP_062074.2; NM_019201.3.
DR   RefSeq; XP_017454636.1; XM_017599147.1.
DR   PDB; 1HKU; X-ray; 2.30 A; A=1-350.
DR   PDB; 1HL3; X-ray; 3.10 A; A=1-350.
DR   PDB; 2HU2; X-ray; 2.85 A; A=1-350.
DR   PDB; 3GA0; X-ray; 3.40 A; A=1-350.
DR   PDBsum; 1HKU; -.
DR   PDBsum; 1HL3; -.
DR   PDBsum; 2HU2; -.
DR   PDBsum; 3GA0; -.
DR   SMR; Q9Z2F5; -.
DR   BioGRID; 248034; 4.
DR   IntAct; Q9Z2F5; 4.
DR   MINT; Q9Z2F5; -.
DR   STRING; 10116.ENSRNOP00000062945; -.
DR   iPTMnet; Q9Z2F5; -.
DR   PhosphoSitePlus; Q9Z2F5; -.
DR   jPOST; Q9Z2F5; -.
DR   PaxDb; Q9Z2F5; -.
DR   PRIDE; Q9Z2F5; -.
DR   GeneID; 29382; -.
DR   KEGG; rno:29382; -.
DR   UCSC; RGD:2441; rat.
DR   CTD; 1487; -.
DR   RGD; 2441; Ctbp1.
DR   eggNOG; KOG0067; Eukaryota.
DR   HOGENOM; CLU_019796_1_3_1; -.
DR   InParanoid; Q9Z2F5; -.
DR   OrthoDB; 700058at2759; -.
DR   PhylomeDB; Q9Z2F5; -.
DR   Reactome; R-RNO-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-RNO-3899300; SUMOylation of transcription cofactors.
DR   Reactome; R-RNO-4641265; Repression of WNT target genes.
DR   EvolutionaryTrace; Q9Z2F5; -.
DR   PRO; PR:Q9Z2F5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; Q9Z2F5; RN.
DR   GO; GO:0005737; C:cytoplasm; IMP:CAFA.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; ISO:RGD.
DR   GO; GO:0017053; C:transcription repressor complex; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; ISO:RGD.
DR   GO; GO:0001226; F:RNA polymerase II transcription corepressor binding; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0008134; F:transcription factor binding; ISO:RGD.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; TAS:RGD.
DR   GO; GO:0006342; P:chromatin silencing; ISO:RGD.
DR   GO; GO:0061025; P:membrane fusion; TAS:RGD.
DR   GO; GO:0035067; P:negative regulation of histone acetylation; ISO:RGD.
DR   GO; GO:0090241; P:negative regulation of histone H4 acetylation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0031065; P:positive regulation of histone deacetylation; ISO:RGD.
DR   GO; GO:0099526; P:presynapse to nucleus signaling pathway; IDA:SynGO.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0050872; P:white fat cell differentiation; ISS:UniProtKB.
DR   CDD; cd05299; CtBP_dh; 1.
DR   DisProt; DP00499; -.
DR   InterPro; IPR043322; CtBP.
DR   InterPro; IPR006139; D-isomer_2_OHA_DH_cat_dom.
DR   InterPro; IPR029753; D-isomer_DH_CS.
DR   InterPro; IPR029752; D-isomer_DH_CS1.
DR   InterPro; IPR006140; D-isomer_DH_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF00389; 2-Hacid_dh; 1.
DR   Pfam; PF02826; 2-Hacid_dh_C; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00065; D_2_HYDROXYACID_DH_1; 1.
DR   PROSITE; PS00671; D_2_HYDROXYACID_DH_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Cell junction; Cytoplasm; Differentiation;
KW   Direct protein sequencing; Isopeptide bond; NAD; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Repressor; Synapse; Synaptosome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..430
FT                   /note="C-terminal-binding protein 1"
FT                   /id="PRO_0000076043"
FT   NP_BIND         169..174
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   NP_BIND         226..232
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   NP_BIND         253..255
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   REGION          1..59
FT                   /note="Interaction with GLIS2 1"
FT                   /evidence="ECO:0000250"
FT   REGION          277..349
FT                   /note="Interaction with GLIS2 2"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        255
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        284
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        304
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         89
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   BINDING         193
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   BINDING         279
FT                   /note="NAD"
FT                   /evidence="ECO:0000269|PubMed:12805226,
FT                   ECO:0000269|PubMed:16940172"
FT   SITE            364..365
FT                   /note="Cleavage; by CAPN1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13363"
FT   SITE            377..378
FT                   /note="Cleavage; by CAPN1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13363"
FT   SITE            399..400
FT                   /note="Cleavage; by CAPN1 and CAPN3"
FT                   /evidence="ECO:0000250|UniProtKB:Q13363"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13363"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13363"
FT   CROSSLNK        418
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         41
FT                   /note="A->E: Strongly reduces interaction with E1A."
FT                   /evidence="ECO:0000269|PubMed:12805226"
FT   MUTAGEN         55
FT                   /note="V->R: Strongly reduces interaction with E1A."
FT                   /evidence="ECO:0000269|PubMed:12805226"
FT   MUTAGEN         172
FT                   /note="G->E: Loss dimerization and of NAD binding."
FT                   /evidence="ECO:0000269|PubMed:19351597"
FT   CONFLICT        175
FT                   /note="G -> S (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          18..23
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   TURN            28..30
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           31..34
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   TURN            35..37
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          39..42
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           48..50
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           53..58
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          59..64
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          66..68
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           72..76
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          83..89
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          92..94
FT                   /evidence="ECO:0007744|PDB:1HL3"
FT   HELIX           96..101
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          105..107
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          111..113
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           114..130
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           132..140
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           148..154
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   TURN            155..157
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          165..169
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           173..183
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   TURN            184..186
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          188..192
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          194..196
FT                   /evidence="ECO:0007744|PDB:3GA0"
FT   HELIX           200..203
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           212..218
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          220..224
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          230..232
FT                   /evidence="ECO:0007744|PDB:1HL3"
FT   HELIX           238..243
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          248..252
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           256..258
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           261..269
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          272..279
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          282..285
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          288..291
FT                   /evidence="ECO:0007744|PDB:1HL3"
FT   TURN            292..295
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          297..301
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           310..329
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   TURN            332..334
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   STRAND          337..340
FT                   /evidence="ECO:0007744|PDB:1HKU"
FT   HELIX           342..344
FT                   /evidence="ECO:0007744|PDB:3GA0"
SQ   SEQUENCE   430 AA;  46628 MW;  0A36DBF27E6A8605 CRC64;
     MSGVRPPIMN GPMHPRPLVA LLDGRDCTVE MPILKDVATV AFCDAQSTQE IHEKVLNEAV
     GALMYHTITL TREDLEKFKA LRIIVRIGSG FDNIDIKSAG DLGIAVCNVP AASVEETADS
     TLCHILNLYR RTTWLHQALR EGTRVQSVEQ IREVASGAAR IRGETLGIIG LGRVGQAVAL
     RAKAFGFNVL FYDPYLSDGI ERALGLQRVS TLQDLLFHSD CVTLHCGLNE HNHHLINDFT
     VKQMRQGAFL VNTARGGLVD EKALAQALKE GRIRGAALDV HESEPFSFSQ GPLKDAPNLI
     CTPHAAWYSE QASIEMREEA AREIRRAITG RIPDSLKNCV NKDHLTAATH WASMDPAVVH
     PELNGAAYSR YPPGVVSVAP TGIPAAVEGI VPSAMSLSHG LPPVAHPPHA PSPGQTVKPE
     ADRDHTTDQL
//
